Dynasil Announces Dr. Gerald Entine as New Director

WEST BERLIN, N.J.--(Business Wire)--
Dynasil Corporation of America (OTCBB:DYSL.OB) announced today that Dr. Gerald
Entine, Founder and President of its wholly owned subsidiary Radiation
Monitoring Devices, Inc. ("RMD") has joined the Dynasil Board of Directors.

Dr. Entine brings to the board more than 40 years of experience in optics,
nuclear sensors and instruments. He received his B.Sc. in Physics/Biophysics,
M.A. in Physics from the University of Pennsylvania and he received his Ph.D. in
Physics from the University of California at Berkeley under the direction of two
Nobel Laureates - Dr. Melvin Calvin and Dr. Owen Chamberlain.

Dynasil Chairman, Mr. James Saltzman stated that: "With the growth that we are
experiencing in our contract research and the vast potential that we see from
the commercialization of the resulting technologies, we welcome Dr. Entine and
look forward to his contribution to the Board." Dynasil CEO, Mr. Craig Dunham,
added, "Under Dr. Entine`s guidance, we have achieved above twenty percent
growth in contract research awarded from July 2008 through June 2009 as compared
to the previous twelve months. Commercialization of our technology portfolio has
become a major focus and we are planning to accomplish this while maintaining
our uninterrupted record of significant and profitable growth."

About Dynasil: Dynasil has achieved profitable growth from $2 million in
revenues to a running rate of $35 million during the past four years. It derives
the majority of its revenue from contract research for government and private
industry and is a manufacturer of specialized instruments and products for a
broad range of applications markets in the medical, industrial, and homeland
security/ defense sectors.

This news release may contain forward-looking statements usually containing the
words "believe," "expect," "work", "plan", or similar expressions. These
statements are made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act. Future results of operations, projections, and
expectations, which may relate to this release, involve certain risks and
uncertainties that could cause actual results to differ materially from the
forward-looking statements. Factors that would cause or contribute to such
differences include, but are not limited to, the factors detailed in the
Company's Annual Report or Form 10-KSB and in the Company's other Securities and
Exchange Commission filings, continuation of existing market conditions and
demand for our products and services.

Dynasil Corporation of America
Patty Kehe
607-272-3320, ext. 26
pkehe@DynasilCorp.com

Copyright Business Wire 2009